PAI
MRNA icon

Pittenger & Anderson Inc’s Moderna MRNA Stock Holding History

Pittenger & Anderson Inc’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-185
Closed -$47K – 474
2021
Q4 		$47K Hold
185
– – ﹤0.01% 271
2021
Q3 		$71K Buy
185
+50
+37% +$18.4K ﹤0.01% 252
2021
Q2 		$32K Hold
135
– – ﹤0.01% 274
2021
Q1 		$18K Buy
+135
New +$19.6K ﹤0.01% 295

Other funds holding MRNA

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Coatue Management
Coatue Management New York $29.1B AUM 96.54% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Pittenger & Anderson Inc's MRNA Position: Q1 2022 in Review

Pittenger & Anderson Inc sold out of Moderna (MRNA) in Q1 2022, closing a stake of 185 shares — an estimated $47K sold.

Pittenger & Anderson Inc first reported a position in MRNA in Q1 2021 and held it in 4 quarters. The position peaked at $71K in Q3 2021. 1,006 funds tracked by Wall St. Rank hold MRNA as of Q1 2022.

  • Pittenger & Anderson Inc reported no remaining Moderna position as of Q1 2022 after selling out during the quarter.
  • Pittenger & Anderson Inc sold 185 Moderna shares in Q1 2022, an estimated $47K.
  • Pittenger & Anderson Inc first reported a position in Moderna in Q1 2021 and held it in 4 quarters.
  • Pittenger & Anderson Inc's Moderna position peaked at $71K in Q3 2021.
  • 1,006 funds tracked by Wall St. Rank held Moderna as of Q1 2022.

Based on Pittenger & Anderson Inc's 13F filing for Q1 2022, filed 28 Apr 2022.